Literature DB >> 26078451

Inflammation and Neovascularization in Hip Impingement: Not Just Wear and Tear.

Cameron J Elias-Jones1, Luke Farrow2, James H Reilly2, Shauna Kerr2, R M Dominic Meek3, Michael P Kelly4, J Luke Campton4, Neal L Millar5.   

Abstract

BACKGROUND: Femoroacetabular impingement (FAI) is a significant cause of osteoarthritis (OA) in young active patients, but the pathophysiology remains unclear. Increasingly, mechanistic studies point toward an inflammatory component in OA.
PURPOSE: This study aimed to characterize inflammatory cell subtypes and neovascularization in FAI by exploring the phenotype and quantification of inflammatory cells and neovascularization in FAI versus OA samples. STUDY
DESIGN: Descriptive laboratory study.
METHODS: Ten samples of the labrum were obtained from patients with FAI (confirmed diagnosis) during open osteochondroplasty or hip arthroscopic surgery. Control samples of the labrum were collected from 10 patients with OA who were undergoing total hip arthroplasty. Labral biopsy specimens were evaluated immunohistochemically by quantifying the presence of macrophages (CD68, CD206, interleukin-13 [IL-13]), T cells (CD3), mast cells (mast cell tryptase), and vascular endothelium (CD34, vascular endothelial growth factor).
RESULTS: Labral biopsy specimens obtained from patients with FAI exhibited significantly greater macrophage, mast cell, and vascular endothelium expression compared with control OA labral samples (P < .05). The most significant difference was noted in macrophage (P < .01) and mast cell (P < .05) expression. Further subtyping of macrophages in FAI using the CD206 tissue marker and IL-13 revealed an M2 phenotype, suggesting that these cells are involved in a regenerate versus degenerate process. There was a modest but significant correlation between mast cells and CD34 expression (r = 0.4, P < .01) in FAI samples.
CONCLUSION: This study provides evidence for an inflammatory cell infiltrate in FAI along with significant neovascularization. In particular, the significant infiltration of mast cells and macrophages was demonstrated, suggesting a role for innate immune pathways in the events that mediate hip impingement. CLINICAL RELEVANCE: Further mechanistic studies to evaluate the net contribution and hence therapeutic utility of these cellular lineages and their downstream processes may reveal novel therapeutic approaches to the management of early hip impingement.
© 2015 The Author(s).

Entities:  

Keywords:  femoroacetabular; hip; impingement; inflammation; young adults

Mesh:

Substances:

Year:  2015        PMID: 26078451     DOI: 10.1177/0363546515588176

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  5 in total

1.  Expression profile of matrix metalloproteinases in the labrum of femoroacetabular impingement.

Authors:  Jason Schon; Jorge Chahla; Sharada Paudel; Lumanti Manandhar; Tyler Feltham; Johnny Huard; Marc Philippon; Zijun Zhang
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

2.  Imbalance of M1/M2 macrophages is linked to severity level of knee osteoarthritis.

Authors:  Baolong Liu; Maoquan Zhang; Jingming Zhao; Mei Zheng; Hao Yang
Journal:  Exp Ther Med       Date:  2018-10-11       Impact factor: 2.447

3.  Are femoroacetabular impingement tomographic angles associated with the histological assessment of labral tears? A cadaveric study.

Authors:  Leandro Ejnisman; Benjamin G Domb; Felipe Souza; Consuelo Junqueira; Jose Ricardo Negreiros Vicente; Alberto Tesconi Croci
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

Review 4.  The Natural History of Femoroacetabular Impingement.

Authors:  Benjamin D Kuhns; Alexander E Weber; David M Levy; Thomas H Wuerz
Journal:  Front Surg       Date:  2015-11-16

5.  Distinct Pattern of Inflammation of Articular Cartilage and the Synovium in Early and Late Hip Femoroacetabular Impingement.

Authors:  Masahiko Haneda; Muhammad Farooq Rai; Lei Cai; Robert H Brophy; Regis J O'Keefe; John C Clohisy; Cecilia Pascual-Garrido
Journal:  Am J Sports Med       Date:  2020-08       Impact factor: 6.202

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.